Skip to main content
. 2018 Mar 19;8:4802. doi: 10.1038/s41598-018-23037-7

Figure 1.

Figure 1

(A) Overview of the proteomic strategies used to stratify cardiovascular risk in individuals aged between 30–50 years old. (B) Experimental design consisting of two different discovery phases, one of them using depleted plasma and the other analyzing non-depleted plasma from an independent cohort of patients. Moreover, a confirmation phase was performed employing two orthogonal techniques, selected reaction monitoring (SRM) and turbidimetry.